Clinical Trials Browser

Phase 2 × OTHER × Tuberous Sclerosis × Clear all

NCT05104983 2026-01-22

TSC-STEPS

Phase 2 Recruiting

Epilepsy, Tuberous Sclerosis

NCT06081348 2025-07-16

CALM

Phase 2 Recruiting

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

NCT02849457 2024-08-19

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

Phase 2 Completed

84 enrolled 16 charts

Tuberous Sclerosis

NCT02451696 2021-09-01

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

Phase 2 Completed

15 enrolled 9 charts

Focal Cortical Dysplasia, Epilepsy, Tuberous Sclerosis

NCT01929642 2021-03-29

RAPT

Phase 2 Completed

3 enrolled 10 charts

Autistic Disorder, Tuberous Sclerosis, Self-Injurious Behavior

NCT01526356 2020-10-26

Treatment

Phase 2 Completed

179 enrolled 13 charts

Tuberous Sclerosis, Angiofibroma

NCT02201212 2020-09-16

Everolimus for Cancer With TSC1 or TSC2 Mutation

Phase 2 Completed

30 enrolled 12 charts

Tuberous Sclerosis

NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Phase 2 Unknown

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

NCT01954693 2018-01-30

TRON

Phase 2 Unknown

Tuberous Sclerosis

NCT01289912 2018-01-25

TSC

Phase 2 Completed

52 enrolled 12 charts

Autistic Disorder, Tuberous Sclerosis

NCT02104011 2018-01-23

STBETA

Phase 2 Completed

Tuberous Sclerosis

NCT00490789 2008-04-30

TESSTAL

Phase 2 Unknown

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00457808 2007-04-09

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Phase 2 Completed

Tuberous Sclerosis, Lymphangioleiomyomatosis